top of page
Browse by category
Search
GLP-1RA may reduce the risk of specific obesity-associated cancers
Glucagon-like peptide 1 receptor agonists (GLP-1RA) may reduce the risk of specific obesity-associated cancers, according to a study by...
GLP-1 medications safe to continue before surgery in patients with diabetes and obesity
There are only mild differences in gastric emptying among patients taking glucagon-like peptide-1 (GLP-1) receptor agonist medications...
Sciwind begins clinical trial of XW014 for Obesity and T2DM
Sciwind Biosciences has initiated of dosing in a Phase 1 clinical trial evaluating XW014, a novel oral small molecule glucagon-like...
Browse by tag
bottom of page